“Eric is a highly conscientious performer that is always interested in improving and achieving more. Although he takes his professional life very seriously, he is also highly personable and a pleasure to work with.”
About
I am a senior sales and business development professional for the contract research (CRO)…
Activity
-
UBC's REMS leaders will be at the REMS Innovation Summit later this month - join us there as we and other industry leaders discuss the future of…
UBC's REMS leaders will be at the REMS Innovation Summit later this month - join us there as we and other industry leaders discuss the future of…
Liked by Eric Hauser
-
Are you helping your patients clear nonmedical hurdles to their therapy access and adherence? Go through our social determinants of health scorecard…
Are you helping your patients clear nonmedical hurdles to their therapy access and adherence? Go through our social determinants of health scorecard…
Liked by Eric Hauser
-
Patient services are undergoing rapid changes based on regulatory requirements and evolving patient and prescriber expectations. Read the full…
Patient services are undergoing rapid changes based on regulatory requirements and evolving patient and prescriber expectations. Read the full…
Liked by Eric Hauser
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
-
-
Publications
-
N-butyldeoxyglactonojirimycin reduces neonatal ganglioside content in a mouse model of GM1 gangliosidosis.
J. Neurochem.
Kasperzyk J.L, El-Abbadi M.M., Hauser E.C., d’Azzo A, Platt F.M., and Seyfried T.N. (2005) N-butyldeoxyglactonojirimycin reduces neonatal ganglioside content in a mouse model of GM1 gangliosidosis. J. Neurochem.
Other authors -
-
Inheritance of Lysosomal Acid beta-Galactosidase Activity and Gangliosides in Crosses of DBA/2J and Knockout Mice.
Biochemical Genetics
Hauser E.C., Kasperzyk J.L., d’Azzo A, and Seyfried T.N. (2004) Inheritance of Lysosomal Acid beta-Galactosidase Activity and Gangliosides in Crosses of DBA/2J and Knockout Mice. Biochem. Genetics
Other authors -
-
Inheritance of brain beta-galactosidase activities and gangliosides in crosses of DBA/2J and knockout mice.
J. Neurochem
Hauser E.C., d’Azzo A, and Seyfried T.N. (2002) Inheritance of brain beta-galactosidase activities and gangliosides in crosses of DBA/2J and knockout mice. J. Neurochem. 81 (Suppl. 1), 11.
Other authors -
Honors & Awards
-
Medpace 100 Club - 2017
Medpace
In recognition for dedication and focus on outstanding customer service and overachievement to goal.
-
Outstanding Sales Perfomance 2012
Medpace
Recommendations received
-
LinkedIn User
7 people have recommended Eric
Join now to viewMore activity by Eric
-
Meet Antoinette Messulam-Defaux. She has worked in Pharmacovigilance since 2011, leading all aspects of clinical trials, post-marketing, and medical…
Meet Antoinette Messulam-Defaux. She has worked in Pharmacovigilance since 2011, leading all aspects of clinical trials, post-marketing, and medical…
Liked by Eric Hauser
-
As oncology therapies become increasingly complex, be confident in your safety and risk management activities with UBC's quality-driven…
As oncology therapies become increasingly complex, be confident in your safety and risk management activities with UBC's quality-driven…
Liked by Eric Hauser
-
Managing pharmacovigilance (PV) data optimization and adhering to evolving regulatory requirements doesn’t have to be a challenge. Experience…
Managing pharmacovigilance (PV) data optimization and adhering to evolving regulatory requirements doesn’t have to be a challenge. Experience…
Liked by Eric Hauser
-
To best address social determinants of health challenges, advance health equity, and achieve better health outcomes for patients, leverage our SDOH…
To best address social determinants of health challenges, advance health equity, and achieve better health outcomes for patients, leverage our SDOH…
Liked by Eric Hauser
-
DIA 2024 has begun! Stop by booth 2201 to discuss better patient outcomes through modernized evidence development. Learn more or get in touch with…
DIA 2024 has begun! Stop by booth 2201 to discuss better patient outcomes through modernized evidence development. Learn more or get in touch with…
Liked by Eric Hauser
-
Meet Helena Pedrosa. Dr. Pedrosa has 11 years of experience in the pharmaceutical industry and holds a PharmD and a PhD in Toxicology. As Associate…
Meet Helena Pedrosa. Dr. Pedrosa has 11 years of experience in the pharmaceutical industry and holds a PharmD and a PhD in Toxicology. As Associate…
Liked by Eric Hauser
-
As patient access and affordability become greater challenges for oncology patients, are your patient access programs right for your therapy and…
As patient access and affordability become greater challenges for oncology patients, are your patient access programs right for your therapy and…
Liked by Eric Hauser
-
Join UBC at DIA's Global Annual Meeting this year to discover the value, challenges, and lessons learned when enriching your clinical trial with…
Join UBC at DIA's Global Annual Meeting this year to discover the value, challenges, and lessons learned when enriching your clinical trial with…
Liked by Eric Hauser
-
Meet Michel Rempel, UBC Pharmacovigilance expert. She has 14 years of experience, leading diverse clinical trials, post-marketing, and medical device…
Meet Michel Rempel, UBC Pharmacovigilance expert. She has 14 years of experience, leading diverse clinical trials, post-marketing, and medical device…
Liked by Eric Hauser
-
Meet Helena Pedrosa. Dr. Pedrosa has 11 years of experience in the pharmaceutical industry and holds a PharmD and a PhD in Toxicology. As Associate…
Meet Helena Pedrosa. Dr. Pedrosa has 11 years of experience in the pharmaceutical industry and holds a PharmD and a PhD in Toxicology. As Associate…
Liked by Eric Hauser
-
Need a real-time, user-friendly pharmacovigilance (PV) analytics solution that allows simple data visualization? Use our PV Tableau Data Analytics…
Need a real-time, user-friendly pharmacovigilance (PV) analytics solution that allows simple data visualization? Use our PV Tableau Data Analytics…
Liked by Eric Hauser
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Eric Hauser in United States
-
Eric Hauser
-
Eric Hauser
Managing Partner, Somera Private Equity
-
Eric Hauser
-
Eric Hauser
Fostering an employee-centered workplace to enable people to be themselves and do their best work
-
eric hauser
112 others named Eric Hauser in United States are on LinkedIn
See others named Eric Hauser